Table 2 Patients and grades of hypocalcemia after denosumab use.
From: Denosumab for dialysis patients with osteoporosis: A cohort study
Grade* of the lowest serum calcium | Non-HD (n = 203) | HD | p-value | |||
|---|---|---|---|---|---|---|
CKD G1,2 (n = 104) | CKDG3a (n = 44) | CKDG3b (n = 35) | CKDG4,5 (n = 20) | (n = 121) | ||
Grade 1 (8.0 ≦ Ca < 8.5) | 1(1.0%) | 1(2.3%) | 3(8.6%) | 5 (25%) | 21(17%) | 0.05 |
Grade 2 (7.0 ≦ Ca < 8.0) | 0 | 0 | 0 | 0 | 22(18%) | 0.003 |
Grade 3–5 (Ca < 7.0) | 0 | 0 | 0 | 1(5%)** | 0 | n/a |
